Fragmentation of Care in Patients with Peritoneal Metastases Undergoing Cytoreductive Surgery

CONCLUSIONS: There were no significant differences in survival or SAEs based on the networks of systemic therapy delivery. This suggests that patients undergoing CRS at a high-volume center may safely receive systemic therapy at outside-network facilities with comparable outcomes.PMID:37737968 | DOI:10.1245/s10434-023-14318-1

Source: Ann Oncol - September 22, 2023 Category: Cancer & Oncology Authors: Mason Vierra Varun V Bansal Ryan B Morgan Hunter D D Witmer Biren Reddy Ankit Dhiman Frederick A Godley Cecilia T Ong Erika Belmont Blas é Polite Ardaman Shergill Kiran K Turaga Oliver S Eng Source Type: research